Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 58 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 58 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| +2.87% | +4.57% | +68.97% | +119.22% | 55.19B | |
| +4.00% | +7.14% | +63.67% | +68.77% | 45.75B | |
| -0.77% | -0.67% | -15.34% | -15.95% | 22.98B | |
| +2.93% | +1.17% | -3.97% | +384.78% | 20.76B | |
| -0.26% | -0.58% | +27.55% | -18.57% | 16.26B | |
| +1.16% | +3.86% | +20.23% | -36.42% | 15.42B | |
| -1.08% | -3.11% | +27.20% | +158.30% | 13.05B | |
| +3.30% | +15.02% | +133.24% | +273.89% | 12.45B | |
| -5.63% | -6.39% | +21.79% | - | 12.37B | |
| Average | -0.02% | +3.55% | +38.15% | +116.75% | 23.8B | |
| Weighted average by Cap. | +1.66% | +3.92% | +43.54% | +108.79% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.42M 5.01M 4.68M 8.78M 586M 8.84M 59.55M 23.17M 288M 23.28M 22.77M 1B | 1.5M 1.31M 1.21M 1.13M 2.12M 142M 2.14M 14.41M 5.61M 69.69M 5.63M 5.51M 242M |
| Net income | -9.7M -8.48M -7.84M -7.32M -13.74M -917M -13.85M -93.21M -36.27M -451M -36.44M -35.65M -1.57B | -24.97M -21.82M -20.18M -18.84M -35.37M -2.36B -35.63M -240M -93.33M -1.16B -93.76M -91.73M -4.03B |
| Net Debt | - | - |
Employees
13
